No Data
Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
innotek (688253.SH): As of the end of November, the company has repurchased a total of 1.1861 million shares.
On December 1st, Gelonghui reported that innotek (688253.SH) announced that as of November 30, 2024, the company repurchased 1,186,052 shares through the centralized bidding trading method using the shanghai Stock Exchange trading system, accounting for 0.8692% of the company's total share capital of 136,458,196 shares. The highest transaction price was 45.37 yuan/share, the lowest price was 35.93 yuan/share, and the total payment amounted to 50,012,613.73 yuan (excluding stamp tax, transaction commissions, and other transaction fees).
There Are Reasons To Feel Uneasy About Innovita Biological Technology's (SHSE:688253) Returns On Capital
Third Quarter Report 2024
Innotek (688253.SH): The net income for the first three quarters was 0.24 billion yuan, a year-on-year increase of 182.65%.
Gelonghui October 25th | Innotek (688253.SH) released its third-quarter report, with a third-quarter revenue of 0.52 billion yuan, an 87.05% year-on-year increase, a net income of 0.24 billion yuan, a 182.65% year-on-year increase, a non-net income of 0.22 billion yuan, a 239.12% year-on-year increase, and basic earnings per share of 1.80 yuan.
Innotek (688253.SH) subsidiary recently obtained 4 product qualifications
Innotek (688253.SH) announced that its wholly-owned subsidiary Innotek (Tangshan) Biotechnology Co., Ltd...
Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
No Data
